Sabrina Lusvarghi, n/a

Division of Viral Products, Office of Vaccine Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Admninistration

Disclosure(s): No financial relationships to disclose

Poster(s):

• 1047 - Asymptomatic SARS-CoV-2 Infections, BNT162b2 mRNA COVID 19 Vaccine-Related Symptoms, and Correlates of Immunity in Post-Vaccination Breakthrough Infections in the Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) Study
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET